Somatic PTPN11 Mutation in a Child With Neuroblastoma and Protein Losing Enteropathy

J Pediatr Hematol Oncol. 2018 May;40(4):328-330. doi: 10.1097/MPH.0000000000000903.

Abstract

Neuroblastoma and protein losing enteropathy (PLE) are diagnoses commonly seen by oncologists and gastroenterologists, respectively. The concurrence of these 2 entities is rare, and not well explained. We describe the sixth case of PLE in a child with neuroblastoma, and the first for which genetic information is available. Tumor DNA had a mutation in the PTPN11 gene, which has been described in neuroblastoma, and in Noonan syndrome-a diagnosis in which neuroblastoma and PLE independently have been reported. Constitutional DNA was normal. Genetic studies in future patients will be needed to support the link between neuroblastoma and PLE.

Publication types

  • Case Reports

MeSH terms

  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / metabolism
  • Female
  • Humans
  • Infant
  • Mutation*
  • Neuroblastoma / enzymology
  • Neuroblastoma / genetics*
  • Neuroblastoma / pathology
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11 / genetics*
  • Protein-Losing Enteropathies / enzymology
  • Protein-Losing Enteropathies / genetics*
  • Protein-Losing Enteropathies / pathology

Substances

  • DNA, Neoplasm
  • PTPN11 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11